Quest For Longevity - Improve Your Health, Slow Aging and Live a Long Life
GLP-1 weight loss drugs like Ozempic, Wegovy and Mounjaro are transforming obesity treatment. But how do GLP-1 injections actually work? How much weight can you lose, what are the side effects, how much do they cost, and what happens when you stop taking semaglutide? In this episode we examine the evidence behind GLP-1 medications, their risks, benefits and long-term impact on health. Common GLP-1 Weight Loss Drug Questions Answered in This Episode * What are GLP-1 and GIP drugs and what are they doing inside my body? * How much weight could I lose on GLP-1 drugs? * What are the benefits of taking GLP-1 drugs? * What are the risks of taking GLP-1 medication? * Will GLP-1 injections cause my muscles to waste? * How much do GLP-1 drugs cost? * Should I take GLP-1 weight loss drugs? Weight Loss Drugs – Timestamps 00:00 – Do you struggle to lose weight? 03:55 – Common questions about weight loss drugs 05:31 – What are GLP-1 drugs and how do they work? 08:25 – How much weight could I lose on weight loss jabs? 11:47 – What are the risks of taking GLP-1 weight loss drugs? 13:53 – Can GLP-1 weight loss injections cause muscle wastage? 17:29 – Should I take GLP-1 weight loss drugs? 19:08 – What happens when I stop taking GLP-1 weight loss medication? 20:33 – How much do GLP-1 weight loss jabs cost? 22:24 – The future of weight loss medication 24:25 – GLP-1 weight loss drugs summary GLP-1 Weight Loss Drugs Research Sources How GLP-1 Drugs Work & Clinical Effectiveness Once-Weekly Semaglutide in Adults with Overweight or Obesity — New England Journal of Medicine [https://www.nejm.org/doi/full/10.1056/NEJMoa2032183] Semaglutide for the Treatment of Overweight and Obesity: A Review — PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10092086/] Cardiovascular & Kidney Benefits Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT Trial) — New England Journal of Medicine [https://www.nejm.org/doi/full/10.1056/NEJMoa2307563] Clinical Outcomes of Tirzepatide or GLP-1 Receptor Agonists in Individuals With Type 2 Diabetes — PMC/JAMA Network Open [https://pmc.ncbi.nlm.nih.gov/articles/PMC11320168/] Tirzepatide Slowed Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes — American Diabetes Association [https://diabetes.org/newsroom/tirzepatide-slowed-progression-chronic-kidney-disease-pateints-with-type-2-diabetes-increased-cardiovascular-disease] Side Effects & Safety Considerations and Interactions with GLP-1 Receptor Agonists — NHS Specialist Pharmacy Service [https://www.sps.nhs.uk/articles/considerations-and-interactions-with-glp-1-receptor-agonists/] GLP-1 Agonists — Diabetes UK [https://www.diabetes.org.uk/about-diabetes/looking-after-diabetes/treatments/tablets-and-medication/glp-1] Weight-Loss Injections Explained — British Heart Foundation [https://www.bhf.org.uk/informationsupport/heart-matters-magazine/medical/weight-loss-injections-explained] Muscle Loss & Sarcopenia Muscle Mass and GLP-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? — Circulation (AHA) [https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.067676] Changes in Lean Body Mass with GLP-1-Based Therapies and Mitigation Strategies — PubMed [https://pubmed.ncbi.nlm.nih.gov/38937282/] Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia — PubMed [https://pubmed.ncbi.nlm.nih.gov/40289060/] Weight Regain After Stopping Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension — PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC9542252/] New Study Finds Stopping Weight-Loss Drugs Is Linked to Faster Regain Than Ending Diet Programmes — University of Oxford [https://www.ox.ac.uk/news/2026-01-08-new-study-finds-stopping-weight-loss-drugs-linked-faster-regain-ending-diet] Fake & Counterfeit Drugs Warning About Sharp Rise in Illegal Medicines Sold in the EU — European Medicines Agency [https://www.ema.europa.eu/en/news/warning-about-sharp-rise-illegal-medicines-sold-eu] Fake Ozempic: WHO Warns of Falsified Semaglutide Sold Online — Medical News Today [https://www.medicalnewstoday.com/articles/fake-ozempic-semaglutide-pens-hospitalizations-severe-sde-effects] WHO Recognition of Obesity as a Chronic Disease & GLP-1 Guidance WHO Issues Global Guideline on the Use of GLP-1 Medicines in Treating Obesity [https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity] Social Channels WhatsApp: https://whatsapp.com/channel/0029VbBpYR2Chq6NOqlcGT0T [https://whatsapp.com/channel/0029VbBpYR2Chq6NOqlcGT0T] Facebook: https://www.facebook.com/TimothyQuin [https://www.facebook.com/TimothyQuin] X: https://x.com/timquin0 [https://x.com/TimQuin0] Instagram: https://instagram.com/timquin0 [https://instagram.com/@timquin0] YouTube: https://youtube.com/timquin0 [https://youtube.com@timquin0] TikTok: https://tiktok.com/timquin1 [https://tiktok.com/timquin1]
31 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de Quest For Longevity - Improve Your Health, Slow Aging and Live a Long Life!